Ayala Pharmaceuticals Inc (fka ADXS)

[zzaatt]

A cynic might say that delaying the results...
enables management to string investors along for several years ...

from:
Mechanistic insights into ADXS11-001
human papillomavirus-associated cancer
immunotherapy (2017)

Brett A. Miles1*, Bradley J. Monk2 and Howard P. Safran3

CONCLUSIONS:
...
The current clinical status of AXAL, which continues to
be assessed in patients with HPV-associated cancers at different
stages, provides optimism for the future of the vaccine
in the treatment of these malignancies. Administered
alone or in combination with various cancer therapies,
AXAL has been proven to be well tolerated by patients
with HPV-associated cancers in multiple investigations,
with early promising signs of antitumor activity also being
reported. These encouraging findings pave the way for
AXAL phase III clinical trials and, at later stages, the potential
introduction of AXAL into the clinical setting.
/CONCLUSIONS

This is the sort of stuff that keeps my cynicism at bay!
How long can you string Drs. Miles,Monk and Safran along?